Malta - inglés - Medicines Authority

doc generici srl via turati, 40-20121, milano, italy - zonisamide - hard capsule - zonisamide 25 mg - antiepileptics

Malta - inglés - Medicines Authority

doc generici srl via turati, 40-20121, milano, italy - zonisamide - hard capsule - zonisamide 50 mg - antiepileptics

Malta - inglés - Medicines Authority

doc generici srl via turati, 40-20121, milano, italy - zonisamide - hard capsule - zonisamide 100 mg - antiepileptics

Malta - inglés - Medicines Authority

endo ventures limited first floor, minerva house, simmonscourt road, ballsbridge, dublin 4, ireland - zonisamide - hard capsule - zonisamide 25 mg - antiepileptics

Malta - inglés - Medicines Authority

endo ventures limited first floor, minerva house, simmonscourt road, ballsbridge, dublin 4, ireland - zonisamide - hard capsule - zonisamide 50 mg - antiepileptics

Malta - inglés - Medicines Authority

endo ventures limited first floor, minerva house, simmonscourt road, ballsbridge, dublin 4, ireland - zonisamide - hard capsule - zonisamide 100 mg - antiepileptics

Estados Unidos - inglés - NLM (National Library of Medicine)

avera mckennan hospital - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg

Estados Unidos - inglés - NLM (National Library of Medicine)

apotex corp. - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide 25 mg

Australia - inglés - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zonisamide, quantity: 50 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; hydrogenated vegetable oil; sodium lauryl sulfate; titanium dioxide; purified water; gelatin; iron oxide black - zonisamide is indicated as:,- monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy who are intolerant to other agents or where other agents are contraindicated;,- adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zonisamide, quantity: 100 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; colloidal anhydrous silica; microcrystalline cellulose; hydrogenated vegetable oil; titanium dioxide; sunset yellow fcf; purified water; allura red ac; gelatin - zonisamide is indicated as:,- monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy who are intolerant to other agents or where other agents are contraindicated;,- adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.